Brokerages Set Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Target Price at $20.89
Shares of Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Free Report) have received an average recommendation of “Buy” from the ten brokerages that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, seven have issued a buy rating and two have given a strong buy rating […]
Shares of Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Free Report) have received an average recommendation of “Buy” from the ten brokerages that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, seven have issued a buy rating and two have given a strong buy rating […]
